–{•¶‚ÖƒXƒLƒbƒv

‰ªŽR‘åŠw–òŠw•”^‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È

TEL. 086-252-1111

§700-8530 ‰ªŽRŒ§‰ªŽRŽs–k‹æ’Ó‡’†1’š–Ú1”Ô1†
>English

Œ´’˜˜_•¶RESEARCH PAPER


y2014z 

46)
Mizuki Horiuchi, Soichiro Moriyama, Yukiko Takahata, Tetsuya Aiba and Yuji Kurosaki:
Effects of peritoneal dialysis on pharmacotherapy: A deductive pharmacokinetic-model approach to predict drug concentration profiles in plasma and peritoneal fluid.
Drug Metab. Pharmacokinet., 29 (2), 154-161 (2014 Apr).


y2012z 

45)
Ayumi Masuda, Yuko Goto, Yuji Kurosaki and Tetsuya Aiba:
In vivo application of chitosan to facilitate intestinal acyclovir absorption in rats.
J. Pharm. Sci., 101 (7), 2449-2456 (2012 Jul).

44)
•è—E“ñA•x‰ª‰À‹vAŽO“c’q•¶A–k‘º‰À‹vF
i‘àj‘—§‘åŠw‚É‚¨‚¯‚éu’·Šú‰Û‘茤‹†‹y‚уAƒhƒoƒ“ƒXƒg‹³ˆçƒvƒƒOƒ‰ƒ€v‚ÌŒ»ó [Development of advanced educational programs including research programs for undergraduate students in National Universities: the facts in 2010].C
Yakugaku Zasshi, 132 (3), 351-356 (2012 Mar).

43)
Junichi Kusaba, Noriko Kajikawa, Hiromu Kawasaki, Yuji Kurosaki and Tetsuya Aiba:
Comparative study on altered hepatic metabolism of CYP3A substrates in rats with glycerol-induced acute renal failure.
Biopharm. Drug Dispos., 33 (1), 22-29 (2012 Jan).


y2011z

42)
Shinsuke Inoue, Tetsuya Aiba, Yasuyuki Masaoka, Keiko Shimizu, Yukiko Komori, Mitsunobu Mio, Shingo Takatori, Hiromu Kawasaki and Yuji Kurosaki:
Pharmacodynamic characterization of nitric oxide-mediated vasodilatory activity in isolated perfused rat mesenteric artery bed.
Biol. Pharm. Bull., 34 (9), 1487-1492 (2011 Sep).

41)
Akemi Ogasawara, Yoshiki Murakami, Nobumasa Yakushiji, Fuminori Ohsawa, Jun-ichi Kusaba, Tetsuya Aiba, Yuji Kurosaki and Hiroki Kakuta:
Pharmacokinetic properties of newly synthesized retinoid X receptor agonist possessing a 6-[N-ethyl-N-(3-alkoxy-4-isopropylphenyl)amino]nicotinic acid skeleton in rats.
Drug Develop. Ind. Pharm., 37 (9), 1060-1067 (2011 Sep).

40)
Satoshi Ueshima, Tetsuya Aiba, Tomoaki Sato, Hisashi Matsunaga, Yuji Kurosaki, Yoko Ohtsuka, Toshiaki Sendo:
Empirical approach for improved estimation of unbound serum concentrations of valproic acid in epileptic infants by considering their physical development.
Biol. Pharm. Bull., 34 (1) 108-113 (2011 Jan).


y2010z

39)
Atsuko Ishikawa, Kentaro Kono, Rie Sakae, Tetsuya Aiba, Hiromu Kawasaki and Yuji Kurosaki:
Altered electrolyte handling of the choroid plexus in rats with glycerol-induced acute renal failure.
Biopharm. Drug Dispos., 31 (8-9), 455-463 (2010 Nov).

38)
Naomi Iihara, Kiyo Suzuki, Yuji Kurosaki, Shushi Morita, Keizo Hori:
Factorial invariance of a questionnaire assessing medication beliefs in Japanese non-adherent groups.
Pharmacy World Sci., 32 (4), 432-439 (2010 Aug).

37)
Akihiro Tanaka, Tetsuya Aiba, Takashi Otsuka, Katsuya Suemaru, Tatsuya Nishimiya, Tomoyoshi Inoue, Mitsuharu Murase, Yuji Kurosaki and Hiroaki Araki:
Population pharmacokinetic analysis of vancomycin using serum cystatin-C as a marker of renal function.
Antimicrob. Agents Chemother., 54 (2), 778-782 (2010 Feb).


y2009z

36)
S. Ueshima, T. Aiba, N. Ishikawa, T. Sato, H. Kawasaki, Y. Kurosaki, Y. Ohtsuka and T. Sendo:
Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
J. Clin. Pharm. Ther., 34 (4), 415-422 (2009 Aug).

35)
Yuki Izuwa, Jun-ichi Kusaba, Mizuki Horiuchi, Tetsuya Aiba, Hiromu Kawasaki and Yuji Kurosaki:
Comparative study of increased plasma quinidine concentration in rats with glycerol- and cisplatin-induced acute renal failure.
Drug Metab. Pharmacokinet., 24 (5), 451-457 (2009 May).

34)
Takashi Makita, Tetsuya Aiba, Yuki Izuwa, Yukiko Komori, Hiromu Kawasaki and Yuji Kurosaki:
Efficacy of peritoneal dialysis of tolbutamide in rats under conditions of the plasma unbound fraction being increased.
Biopharm. Drug Dispos., 30 (1), 1-8 (2009 Jan).


y2008z 

33)
o‰H—SŠîC㓇@’qC²“¡’qºC‰ªè¹—˜C‡—t“N–çCìú±”ŽŒÈC•ú±—E“ñCç“°”NºF
’ŽË—p‰–Ž_ƒoƒ“ƒRƒ}ƒCƒVƒ“»Ü‚Ìæ”­•i‹y‚ь㔭•i‚É‚æ‚ét‹@”\’ቺŽ–—á‚Ì”­Ç󋵂̔äŠrC
Yakugaku Zasshi, 128 (10), 1493-1498 (2008 Oct).

32)
Rie Sakae, Atsuko Ishikawa, Tomoko Niso, Yukiko Komori, Tetsuya Aiba, Hiromu Kawasaki and Yuji Kurosaki:
Decreased Lithium Disposition to Cerebrospinal Fluid in Rats with Glycerol-induced Acute Renal Failure.
Pharm. Res., 25 (10), 2243-2249 (2008 Oct).

31)
Naomi Iihara, Yuji Kurosaki, Chika Miyoshi, Kiyo Takabatake and Shushi Morita:
Changes in attitudes among Japanese patients after Pharmacist Law revision.
Pharmacy World Sci., 30 (3), 258-264 (2008 Jun).

30)
Zen-ichi Masuda, Yuji Kurosaki, Kozo Ishino, Keita Yamauchi, Shunji Sano:
Pharmacokinetic analysis of flomoxef in children undergoing cardiopulmonary bypass and modified ultrafiltration.
General Thoracic Cardiovasular Surgery, 56 (4), 163-169 (2008 Apr).

29)
Satoshi Ueshima, Tetsuya Aiba, Takashi Makita, Shigeki Nishihara, Yoshihisa Kitamura, Yuji Kurosaki, Hiromu Kawasaki, Toshiaki Sendo, Yoko Ohtsuka and Yutaka Gomita:
Characterization of non-linear relationship between total and unbound serum concentrations of valproic acid in epileptic children.
J. Clin. Pharm. Ther., 33 (1), 31-38 (2008 Feb).

28)
Naomi Iihara, Yuji Kurosaki, Chika Miyoshi, Kiyo Takabatake, Shushi Morita and Keizo Hori:
Comparison of individual perceptions of medication costs and benefits
between intentional and unintentional medication non-adherence among
Japanese patients.
Patient Education Counseling, 70 (2), 292-299, (2008 Feb).

27)
Naomi Iihara, Yuji Kurosaki, Mitsutaka Takada and Shushi Morita:
Risk of hypoglycemia associated with thyroid agents is increased in patients with liver impairment.
Int. J. Clin. Pharmacol. Ther., 46 (1), 1-13, (2008 Jan).


y2007z 

26)
Yukiko Komori, Tetsuya Aiba, Chie Nakai, Risa Sugiyama, Hiromu Kawasaki and Yuji Kurosaki:
Capsaicin-induced increase of intestinal cefazolin absorption in rats.
Drug Metabol. Pharmacokinet., 22 (6), 445-449 (2007 Dec).

25)
Hidekatsu Nishimura, Chiaki Hayashi, Tetsuya Aiba, Ichiro Okamoto, Yuji Miyamoto, Susumu Nakade, Kazuhisa Takeda, Yuji Kurosaki:
Application of the correlation of in vitro dissolution behavior and in vivo plasma concentration profile (IVIVC) for soft-gel capsules | A pointless pursuit?
Biol. Pharm. Bull., 30 (11), 2221-2225 (2007 Nov).

24)
Yuji Kurosaki, Masahiro Tagawa, Akiho Omoto, Hiroshi Suito, Yukiko Komori, Hiromu Kawasaki and Tetsuya Aiba:
Evaluation of intramuscular lateral distribution profile of topically administered acetaminophen in rats.
Int. J. Pharm., 343 (1-2), 190-195 (2007 Oct).

23)
“y‹’q–¾C”ÑŒ´‚È‚¨‚ÝC‰Í“Y@mC•Ÿ‰ªŒ›‘×C–F’n@ˆêC•è—E“ñCX“cC”VF
ŒÂX‚ÌŠ³ŽÒ‚Ì•›ì—p—\‘ª‚Ì‚½‚ß‚ÉŠJ”­‚³‚ꂽ•wl‰È‚ª‚ñ‰»Šw—Ö@ƒ‚ƒjƒ^ƒŠƒ“ƒOƒV[ƒg.
Yakugaku ZasshiC127 (6), 1027-1033 (2007 Jun).

22)
Yukiko Komori, Tetsuya Aiba, Risa Sugiyama, Chie Nakai, Hiromu Kawasaki and Yuji Kurosaki:
Effect of capsaicin on intestinal cephalexin absorption in rats.
Biol. Pharm. Bull., 30 (3), 547-551 (2007 Apr).

21)
Yukiko Komori, Tetsuya Aiba, Miki Kushima, Hiromu Kawasaki and Yuji Kurosaki:
Alteration of therapeutic efficacy of lipid microspheres incorporating prostaglandin E1 by mixing with aqueous solution.
J. Pharm. Sci., 96 (4), 935-943 (2007 Mar).


yOther significant reports (2001-2006)z 

Tetsuya Aiba, Mizuki Horiuchi, Takashi Makita, Yukiko Komori, Hiromu Kawasaki and Yuji Kurosaki:
Peritoneal dialysis alters tolbutamide pharmacokinetics in rats with experimental acute renal failure.
Drug Metabol. Pharmacokinet., 21 (4), 291-296 (2006 Aug).

Hiroo Maeda, Toshihiko Sugie, Akihiko Sano, Hiromu Kawasaki and Yuji Kurosaki:
Study on accelerated evaluation system for release profiles of covered-rod type silicone formulation using indomethacin as a model drug.
J. Controlled Release, 94 (3), 337-349 (2004 Feb).

Hiroo Maeda, Erika Ohashi, Akihisa Sano, Hiromu Kawasaki and Yuji Kurosaki:
Investigation of release behavior of covered-rod type formulation using silicone.
J. Controlled Release, 90 (1), 59-70 (2003 Jun).

Keita Yamauchi, Shoji Yasunaga, Hiromu Kawasaki and Yuji Kurosaki:
An approach to predict the ductus-arteriosus dilating effect induced by lipo-prostaglandin E1 in newborn rats lacking plasma concentration-time data by the pharmacological response kinetic model.
Biol. Pharm. Bull., 26 (2), 210-215 (2003 Feb).



»ÜÝŒv•]‰¿Šw

§700-8530
‰ªŽRŒ§‰ªŽRŽs–k‹æ’Ó‡’†1’š–Ú1”Ô1†

TEL 086-252-1111

newpage15.html‚ւ̃Šƒ“ƒN